
# Title 37 - Patents, Trademarks, and Copyrights
## Chapter I - United States Patent and Trademark Office, Department of Commerce
### Subchapter A - General
#### PART 1 - RULES OF PRACTICE IN PATENT CASES
##### Subpart G - Biotechnology Invention Disclosures
###### Application Disclosures Containing Nucleotide and/or Amino Acid Sequences
####### ยง 1.834 Form and format for nucleotide and/or amino acid sequence submissions as the "Sequence Listing XML" in patent applications filed on or after July 1, 2022.
######## see

(2) Be in XML format, where all permitted printable characters (including the space character) and non-printable (control) characters are defined in paragraph 40 of WIPO Standard ST.26 (incorporated by reference,ยง 1.839).

(3) Be named as *.xml, where "*" is one character or a combination of characters limited to upper- or lowercase letters, numbers, hyphens, and underscores, and the name does not exceed 60 characters in total, excluding the extension. No spaces or other types of characters are permitted in the file name.

(b) The "Sequence Listing XML" must be in a single file containing the sequence information and be submitted either:

(1) Electronically via the USPTO patent electronic filing system, where the file size must not exceed 100 MB, and file compression is not permitted; or

(2) On read-only optical disc(s) in compliance with ยง 1.52(e), where:

(i) A file that is not compressed must be contained on a single read-only optical disc;

(ii) The file may be compressed using WinZip&#xAE;, 7-Zip, or Unix&#xAE;/Linux&#xAE; Zip;

(iii) A compressed file must not be self-extracting; or

(iv) A compressed XML file that does not fit on a single read-only optical disc may be split into multiple file parts, in accordance with the target read-only optical disc size, and labeled in compliance with ยง 1.52(e)(5)(vi);
